Regulation - Pharmaceutical


Current filters:


Popular Filters

6970 to 6994 of 7190 results

Efficacy and stroke concerns halt trial of Abbott cholesterol drug Niaspan combo


US health care major Abbott Laboratories (NYSE ABT) has halted its AIM-HIGH clinical trial of Niaspan…

Abbott LaboratoriesCardio-vascularNiaspanPharmaceuticalResearchSimvastatin

Canada’s Quebec Province overhauls cancer drug evaluation


The Canadian Province of Quebec, which has the highest incidence of new cancer cases in the country,…

North AmericaPharmaceuticalRegulation

German approval for GW and Almirall’s Sativex for spasticity due to MS


Spain’s leading drugmaker Almirall (ALM) and UK-based originator of the cannabis based product GW…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Several abstracts on gout reveal true burden of disease and highlight promising new treatments


New studies on gout were presented this week at EULAR, the Annual Congress of the European League Against…

allopurinolAnti-Arthritics/RheumaticsKrystexxalesinuradPharmaceuticalRegulationResearchSavient Pharmaceuticals

HAI Europe injects public health perspective into European Research and Innovation Framework


Consumer group Health Action International (HAI) Europe has submitted a response to the European Commission…


Two more product approvals in Russia for India’s Claris


Claris Lifesciences (CLAR: IN), one of the largest sterile injectables pharmaceutical companies in India,…

Antibiotics and Infectious diseasesClaris LifesciencesEuropeFluconazoleGenericsLevofloxacinRegulation

Major stakeholders optimistic about future of drug development, but differ on defining value


Biopharmaceutical executives, managed care executives, physicians and patients with chronic illness foresee…

HealthcareNorth AmericaPharmaceuticalResearch

Synovate Healthcare launches Hyperlipidemia Monitor in Asia-Pacific


Synovate Healthcare, the health care specialist unit of market research firm Synovate, says it has launched…


US Senators accuse Sanofi over lobbying FDA on generic Lovenox


US Senate Finance Committee Chairman Max Baucus (Democrat, Montana) and senior Committee Member Chuck…

Cardio-vascularGenericsLovenoxNorth AmericaPharmaceuticalRegulationSanofi

Patient access and industry competitiveness at stake in EU Transparency Directive review, says EFPIA


With the review of the European Union’s Transparency Directive (Directive 89/105/EEC) gaining momentum,…


Emerging markets continue to drive Nycomed in first quarter 2011


Independent Swiss drugmaker Nycomed, which is the subject of an agreed 9.6 billion-euro takeover by Japan’s…


Vaccine side effects under the microscope in Australia


Australia’s Gillard government yesterday released an independent assessment of the nation's management…


UK’s NICE recommends naftidrofuryl oxalate for symptoms of peripheral arterial disease


The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending…

Cardio-vascularEuropeMerck SerononaftidrofurylPharmaceuticalPraxilenePricingRegulation

Cancer Research UK partners with Centella to develop radiotherapy-enhancing drug


Cancer Research UK and Cancer Research Technology - the charity's development and commercialization arm…

Cancer Research TechnologyCentella TherapeuticsOncologyPharmaceuticalResearchUniServices

Elan investing up to $50 million into the alliance with Proteostasis


Ireland-headquartered Elan Corp (NYSE: ELN) has entered a strategic business relationship to advance…

ElanMergers & AcquisitionsNeurologicalPharmaceuticalProteostasis TherapeuticsResearch

US Presidential visit to UK underlines cooperation in science, innovation and higher education


The joint statement agreed yesterday by UK Prime Minister David Cameron and US President Barack Obama,…

EuropeJohnson & JohnsonNorth AmericaPharmaceuticalResearch

FTC Files Amicus Brief with US Appeals Court to reverse pay-for-delay ruling


Continuing its battle against pay-for-delay between drug originators and generic makers, the US Federal…

GenericsLegalMerck & CoNorth AmericaPatentsPharmaceuticalSchering-Plough

J&J Cilag unit buys Russian OTC brands from J B Chemicals for $260 million


US health care giant Johnson & Johnson’ (NYSE: JNJ) Switzerland-based Cilag GmbH International has…

Cilag GmbHEuropeJ B Chemicals & PharmaceuticalsJohnson & JohnsonMergers & AcquisitionsPharmaceutical

Drug reimbursement in the UK: What impact of value-based pricing?


The UK's coalition government has embarked on a set of health care reforms designed to transform the…


Information overload in drug side effect labeling


The lists of potential side effects that accompany prescription drugs have ballooned in size, averaging…

North AmericaPharmaceuticalRegulation

6970 to 6994 of 7190 results

Back to top